Does neoadjuvant therapy promote or delay metastasis in breast cancer?
Sautter-Bihl, M.L.
Strahlentherapie und Onkologie Organ der Deutschen Rontgengesellschaft . 176(6): 291-292
2000
ISSN/ISBN: 0179-7158 PMID: 10897258 Document Number: 518195
Document emailed within 1 workday
Related Documents
Semiglazov, V.F.; Semiglazov, V.V.; Petrenko, O.L.; Komyakhov, A.V.; Dashyan, G.A.; Paltuev, R.M.; Semiglazova, T.Y.; Manikhas, A.G.; Bozhok, A.A.; Lalak, I.A. 2015: Breast-Conserving Surgery after Neoadjuvant Therapy for Breast Cancer Voprosy Onkologii 61(3): 381-386Litviakov, N.V.; Garbukov, E.I.; Slonimskaia, E.M.; Tsyganov, M.M.; Denisov, E.V.; Vtorushin, S.V.; Khristenko, K.I.; Zav'ialova, M.V.; Cherdyntseva, N.V. 2013: Correlation of metastasis-free survival in patients with breast cancer and changes in the direction of expression of multidrug resistance genes during neoadjuvant chemotherapy Voprosy Onkologii 59(3): 334-340
Schneeweiss, A.; Bastert, G.; Huober, J.; Wallwiener, D.; Hamerla, R.; Lichter, P. 2004: Neoadjuvant therapy with gemcitabine in breast cancer Oncology 18(14 Suppl 12: 27-31
Voznyĭ, E.K.; Gurov, S.N.; Dobrovol'skaia, N.I. 2001: Certain aspects of neoadjuvant therapy of locally advanced breast cancer Voprosy Onkologii 47(6): 690-694
Voznyĭ, E.K.; Gurov, S.N.; Dobrovol'skaia, N.I. 2001: Certain aspects of neoadjuvant therapy of locally advanced breast cancer Voprosy Onkologii 47(6): 690-694
White, J. 2013: Management of the axilla in breast cancer patients undergoing neoadjuvant therapy Clinical Advances in Hematology and Oncology: H&o 11(12): 796-798
Kidogami, S.; Tamura, S.; Endo, S.; Imamura, H.; Yoneda, N.; Mokutani, Y.; Kishimoto, T.; Hashimoto, Y.; Hirose, H.; Ide, Y.; Sasaki, Y. 2019: Advanced Gastric Cancer with Liver Metastasis and Para-Aortic Lymph Node Metastases Treated Effectively Using Neoadjuvant CapeOX Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(13): 2366-2368
Inafuku, K.; Inari, H.; Goto, N.; Kawamoto, M.; Hatori, S.; Tanabe, H.; Masuda, M. 2014: A case of postmenopausal breast cancer becoming HER2 positive after neoadjuvant hormone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(4): 487-489
Von Minckwitz, G.; Loibl, S.; Untch, M. 2012: What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer? Oncology 26(1): 20-26
Konishi, K.; Hasegawa, N.; Kaneko, H.; Iimura, Y.; Shoji, Y.; Kawabata, M. 2010: A case of premenopausal stage IV breast cancer responding to neoadjuvant endocrine therapy after chemotherapy with FEC Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 111-113
Van Schalkwyk, L.; Benn, C.; Bergstrom, K. 2017: Surgery Post Neoadjuvant Therapy for Breast Cancer: An Analysis of 82 Patients Treated at a Specialist Unit in Johannesburg South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 55(3): 75
Novoa Vargas, A.; Font López, K.C.; Amador, D.D. 2011: Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer Ginecologia y Obstetricia de Mexico 79(9): 553-557
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Kihara, M.; Miyauchi, A. 2008: A case of elderly breast cancer achieving partial response by letrozole with stable disease to anastrozole as neoadjuvant endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(4): 687-690
Moiseenko, V.M.; Barishpol'skaia, I.V.; Orlova, R.V.; Protsenko, S.A.; Ermakova, N.A.; Mikhaĭlichenko, T.D.; Semenova, A.I.; Korytova, L.I.; Zhabina, R.M.; Gonta, E.V. 2004: Perspectives in antineoplastic therapy of breast cancer with brain metastasis Voprosy Onkologii 50(2): 250-252
Jiang, J.; Xia, M.; Feng, J.-B.; Kong, B.-H. 2007: Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo Zhonghua Fu Chan Ke Za Zhi 42(6): 398-402
Makino, H.; Iraha, M.; Manba, N.; Hashidate, H.; Shiotani, M. 2012: Utility of serum human epidermal growth factor receptor-2 extracellular domain(HER2 ECD)assessment in patients with advanced or recurrent breast cancer and those who received neoadjuvant therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(2): 237-240
Scotto, V.; Masci, P.; Sbiroli, C. 1985: Breast metastasis of ovarian cancer during cis-platinum therapy. A case report and review of the literature European Journal of Gynaecological Oncology 6(1): 62-65
Kanda, K.; Waki, S.; Uchimura, M.; Kida, H.; Narita, K.; Harada, N. 1990: A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2421-2424
Nakakuma, T.; Takahashi, K.; Ueno, S.; Kondou, Y.; Kosaka, Y.; Sengoku, N. 2017: A Long-Surviving Case of HER2-Positive Breast Cancer with Brain Metastasis Treated through Multidisciplinary Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(12): 1107-1109